Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $38.54B | $36.44B | +5.75% |
Cost of Revenue | $27.6B | $22.18B | +24.42% |
Gross Profit | $10.94B | $14.26B | -23.30% |
Operating Income | $3.55B | $6.34B | -44.08% |
Net Income | $2.45B | $4.61B | -46.84% |
EPS (Basic) | $1.89 | $3.44 | -45.06% |
EPS (Diluted) | $1.89 | $3.42 | -44.74% |
R&D Expense | $400M | $400M | 0.00% |
SG&A Expense | $7.17B | $7.44B | -3.58% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $71.49B | $68.5B | +4.37% |
Current Assets | $12.95B | $13.24B | -2.20% |
Total Liabilities | $45.6B | $41.54B | +9.77% |
Current Liabilities | $21.86B | $19.55B | +11.84% |
Stockholders' Equity | $25.84B | $26.93B | -4.06% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $4.51B | $4.91B | -8.07% |
Investing Cash Flow | $-1.2B | $526M | -327.38% |
Financing Cash Flow | $-2.76B | $-5.78B | +52.27% |
Dividends Paid | $2.49B | $2.35B | +5.87% |
Share Buybacks | $2.38B | $2.33B | +2.19% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Gross Margin | 28.4% | 39.1% | -10.75% |
Operating Margin | 9.2% | 17.4% | -8.20% |
Net Margin | 6.4% | — | — |
ROE | 9.5% | — | — |
ROA | 3.4% | — | — |
Current Ratio | $0.592 | — | — |
Debt to Equity | $1.765 | — | — |
MDLZ experienced a significant decline in profitability despite revenue growth, primarily due to increased cost pressures.
The company achieved a 5.8% increase in revenue, driven by strong sales in emerging markets.
Source: Source: 10-K Item 7, p.45
Cost of revenue increased by 24.4%, significantly impacting gross profit margins.
Source: Source: 10-K Item 7, p.46
Gross margin decreased by 10.7 percentage points due to higher input costs and supply chain disruptions.
Source: Source: 10-K Item 7, p.47
The company faces high input costs, which have significantly reduced profit margins and could continue to impact future profitability.
Source: Source: 10-K Item 1A, p.12
Unlock 2 more detailed risk analysis